Treatment type: Cell therapies

Neonatologist and clinician-scientist Associate Professor Atul Malhotra from The Ritchie Centre, the School of Clinical Sciences at Monash Health,  and Monash Children’s Hospital,  has been awarded a Fulbright Professional Coral Sea Scholarship to support the US implementation of an umbilical cord blood (UCB) cell therapies clinical trial for extremely preterm babies. …  Read more

For the first time in Australia, a child has received an infusion of their own umbilical cord blood stem cells to treat cerebral palsy (CP), and Hudson Cell Therapies played a crucial role in making it happen. The therapy, not yet approved as a standard treatment for CP anywhere in the world, was administered to…  Read more

Despite advances in neonatal care, effective treatments for brain injury in premature babies remain a significant unmet need. Researchers at Hudson Institute of Medical Research, working with the School of Clinical Sciences at Monash Health, are tackling this challenge head-on with an innovative approach: engineered extracellular vesicles.…  Read more

People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most difficult to treat conditions associated with the disease.…  Read more

Pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s Hospital, The School of Clinical Sciences at Monash University, and Hudson Institute of Medical Research, has successfully demonstrated the feasibility and safety of using a baby’s own cord blood-derived cells as a potential treatment for extremely preterm infants.…  Read more

Professor Carl Walkley heads the RNA Biology and Innate Immune Sensing Research Group at Hudson Institute of Medical Research and their latest research, published in Science Immunology, sheds new light on these crucial processes.…  Read more

Hudson Institute researchers are lifting the lid on a treatment promising the benefits of stem cells but none of the drawbacks, offering potential to reduce the lifelong impacts of perinatal lung and brain injuries.…  Read more

Dr Tayla Penny will receive a grant of more than $96,000 from the Cerebral Palsy Alliance to advance her work on improving understanding of umbilical cord blood (UCB) stem cell treatment for perinatal brain injury.…  Read more

A/Prof Lawlor leads the Cell Death and Inflammatory Signalling Group that investigates the intricate links between cell death and inflammation and how these processes impact various inflammatory and infectious diseases. …  Read more

This research has the potential to revolutionise therapies for pelvic floor regeneration and enable personalised medicine for women.…  Read more